New England Journal of Medicine Publishes Study Results Suggesting Veracyte’s Percepta™ Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures in Lung Cancer Diagnosis
May 17, 2015Positive data from Veracyte's AEGIS I and AEGIS II clinical trials, evaluating Percepta Bronchial Genomic Classifier in lung cancer diagnosis, were published in the New England Journal of Medicine. Data from AEGIS II will also be presented at ATS mini-sym
More »
Dicerna Announces Expansion of Ongoing DCR-MYC Phase 1 Study to Evaluate Safety and Efficacy in Patients with Advanced Pancreatic Neuroendocrine Tumors (PNETs)
May 14, 2015Dicerna expands its ongoing Phase 1 study of DCR-MYC in solid tumors, multiple myeloma, or lymphoma to include a cohort of patients with pancreatic neuroendocrine tumors following early signs of clinical and metabolic response and tumor shrinkage.
More »
Sequent Medical Announces Presentation of Compelling Long-Term Clinical Data and Commercial Release
May 12, 2015Sequent Medical presents positive 12-month clinical data for their WEB™ Aneurysm Embolization System at Societe Francaise de Neuroradiologie (SFNR) meeting in Paris, as well as also launching their latest generation WEB product.
More »